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Abstract
Background: Identifying areas that support high malaria risks and where populations lack access to health care is central to
reducing the burden in Afghanistan. This study investigated the incidence of Plasmodium vivax and Plasmodium falciparum
using routine data to help focus malaria interventions.
Methods: To estimate incidence, the study modelled utilisation of the public health sector using fever treatment data from
the 2012 national Malaria Indicator Survey. A probabilistic measure of attendance was applied to population density metrics
to define the proportion of the population within catchment of a public health facility. Malaria data were used in a Bayesian
spatio-temporal conditional-autoregressive model with ecological or environmental covariates, to examine the spatial and
temporal variation of incidence.
Findings: From the analysis of healthcare utilisation, over 80% of the population was within 2 hours’ travel of the nearest
public health facility, while 64.4% were within 30 minutes’ travel. The mean incidence of P. vivax in 2009 was 5.4 (95% Crl
3.2–9.2) cases per 1000 population compared to 1.2 (95% Crl 0.4–2.9) cases per 1000 population for P. falciparum. P. vivax
peaked in August while P. falciparum peaked in November. 32% of the estimated 30.5 million people lived in regions where
annual incidence was at least 1 case per 1,000 population of P. vivax; 23.7% of the population lived in areas where annual P.
falciparum case incidence was at least 1 per 1000.
Conclusion: This study showed how routine data can be combined with household survey data to model malaria incidence.
The incidence of both P. vivax and P. falciparum in Afghanistan remain low but the co-distribution of both parasites and the
lag in their peak season provides challenges to malaria control in Afghanistan. Future improved case definition to determine
levels of imported risks may be useful for the elimination ambitions in Afghanistan.
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Background
Since the Soviet invasion in 1979, Afghanistan has experienced
prolonged periods of insecurity and political instability. Conse-
quently it has some of the poorest socio-economic and health
status indicators globally. The country is ranked the thirteen lowest
on the human development index [1] and has a child mortality
rate of 97 deaths before the age of five years for every 1000
children born [2,3]. In Afghanistan, malaria is an important
disease with approximately half the population at risk [4,5,6].
Malaria transmission in the country is constrained by altitude,
the rugged topography, patchy rainfall and extreme aridity [7].
There is no active malaria transmission in areas greater than 2000
metres above mean sea level [8], while transmission is unstable in
PLOS ONE | www.plosone.org 1 July 2014 | Volume 9 | Issue 7 | e102304
areas with limited annual rainfall. There are at least six malaria
vectors in Afghanistan namely: the Anopheles superpictus, An.
culicifacies, An. hycranus, An. Pulcherimus, An. fluviatilis, and
An. stephensi. The latter two are mainly found in the eastern
provinces [4,9]. Malaria infections are predominantly due to the
Plasmodium vivax parasite although Plasmodium falciparum
infections exist [8].
Afghanistan has a long history of malaria control dating back to
the formation of the Directorate General of Preventive Medicine
and Primary Health Care in 1948 [7]. Earlier vector control efforts
focused on spraying using dichlorodiphenyltrichloroethane (DDT)
and by 1970 the An. superpictus was almost eradicated [7,10,11].
After the Soviet invasion, the national program gradually
weakened and had almost ceased to function [7,12]. Chloroquine
resistance and population movement, mainly from returning
refugees, contributed to an increase in malaria burden in
Afghanistan [12,13,14]. Since 2000, however, substantial resourc-
es have been invested in malaria control in Afghanistan with
support from the Global Fund to fight AIDS, Tuberculosis and
Malaria, the United States Agency for International Development
(USAID) as well as other agencies [15]. Despite the insecurity and
infrastructure challenges, progress has been made in reducing the
burden [5]. A recent malaria indicator survey (MIS) conducted in
2011 showed an average prevalence of less than 1% for both P.
vivax and P. falciparum nationally while 76% of household
clusters had no residents infected.
In the national malaria strategy of 2008–2013, Afghanistan
aimed to reduce, by 60%, the malaria morbidity by 2013 and
reduce P. falciparum cases to near zero with the aim of eventually
interrupting its transmission [15]. The main interventions were
coverage with vector control, parasitological diagnosis and
treatment with effective antimalarials. In addition, a cross-border
initiative was launched with Tajikistan to reduce the risk of
imported infections to Tajikistan and to eliminate P. falciparum
malaria in three border districts.
To track progress towards the national targets, the National
Malaria and Leishmaniasis Control Programme (NMLCP) and
partners established a routine information system to report
monthly malaria cases by health facility [16]. The system,
however, captured passively detected case data from only the
public health system and contained both clinically diagnosed and
parasitologically confirmed P. vivax and P. falciparum cases.
Passive case detection, usually from HMIS, is hindered by the
challenges of the low parasite confirmation rates which inflate
reported malaria caseloads. In addition, low reporting rates tend to
underestimate disease burdens because of the spatially and
temporally incomplete data [17]. To provide more reliable
estimates of disease burden, techniques are required that can
adjust for these deficiencies by smoothing crude incidence rates;
filling in gaps where no health reports have been assembled; and
adjusting for the rate of facility utilisation since only a proportion
of actual cases present at a facility [18].
In this study, a formal spatial and temporal approach, that
incorporates a variety of data sources to estimate malaria
incidence by district from 2006–2009 in Afghanistan, was
developed. First, nationally representative household survey data
from the 2011 MIS were used to characterize the utilisation of
public health facilities and subsequently develop the denominator
(catchment population) weighted by probability of health facility
use for fever treatment. Secondly, malaria cases reported at the
health facilities were used to model incidence of P. vivax and P.
falciparum spatially and temporally using a Bayesian approach
[19]. The clinically reported cases were adjusted using species-
specific slide positivity rates observed at the facility and combined
with parasite species confirmed cases to calculate the numerator.
Slide positivity is the ratio of the number of positive malaria cases
to the total number of people examined usually expressed as a
percentage (rate). The combination of the adjusted cases and
catchment populations were then used to compute the incidence of
both P. vivax and P. falciparum.
Methods
Health management information structure in
Afghanistan
Afghanistan is divided into 34 administrative provinces.
Healthcare is delivered mainly through the Basic Package for
Health Services (BPHS) and the Essential Package for Hospital
Services (EPHS) constituted in 2002 by the Ministry of Public
Health (MoPH) [20,21,22]. In a bid to increase coverage, the
BPHS was expanded through the contracting out of services to
NGOs and MoPH partners [21,23]. The BHC constitutes clinics,
health posts and Maternal Child Health (MCH) centres and
Comprehensive Health Centres (CHC). This is linked to EPHS
made up of the District Hospitals (DH) (first referral level) and
regional or provincial (tertiary) hospitals. At village level commu-
nity health workers manage the health posts and treat mild
conditions and, in some cases, Mobile Health Teams (MHTs) are
used [20,24]. In terms of data reports, tally sheets are filled at these
lower-tier facilities and aggregated at the next tier facilities (CHC)
which are then forwarded to regional directorates [16]. Thus, the
health posts serve as a support network for the health centres and
sometimes malaria cases are reported at the health centre rather
than the individual health unit. The basic health centres link the
basic service providers at the community level with the next service
tier (the CHC) that are, in turn, linked to district hospitals and
regional referral hospitals. Thus, where no regional or tertiary
facility exists, district hospitals are the main referral centres. HMIS
reports are also compiled the regional level and distributed to the
national management level. Inpatient facilities are provided
mainly at the tertiary level [20]. Parasitological diagnosis is
conducted at higher tier facilities (Hospitals) where laboratory
facilities exist while clinical diagnosis is predominantly used at
health posts. The 2010 national malaria treatment guidelines
outline the scale up of diagnostics at all health facilities to ensure
diagnosis prior to treatment.
Data
The malaria case data were obtained from HMIS through the
Afghanistan National Malaria and Leishmaniasis Control Pro-
gramme (NMLCP). This consisted of records from 1,629 public
health facilities for a 48-month period from 2006 to 2009. Data
represented aggregate monthly cases of P. falciparum and P.
vivax. Of the 1,629 health facilities, 1,587 had reported malaria
cases based on both clinical and parasitology examination.
Parasitological diagnosis (microscopy or RDTs) was conducted
at higher-tier facilities (hospitals and health centres) where
laboratory facilities exist while clinical diagnosis was predomi-
nantly used at lower-level facilities such as health posts (File S1).
No cases were examined or reported for 228 facilities which were
treated as missing data while data for mobile units (n=93) were
omitted from the final analysis since they serve as outreach centres
from major facilities. The missing spatial and temporal structures
of data were imputed as ‘NAs’ and predictions made at missing
locations. The spatial coordinates of health facilities were obtained
from the Afghan Management Information Systems (AMIS)
(http://www.aims.org.af/), which was formerly managed by the
United Nations Office for the Coordination of Humanitarian
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Affairs (UNOCHA) and the United Nations Development
Programme (UNDP) in the early 2000s, but became a national
independent Non-Governmental Organisation (NGO) in 2008.
These facilities were either mapped using non-differential hand-
held global positioning systems (GPS) receivers during the
assessment surveys or in some cases the longitude and latitude
were established using a village or settlement database. For
analysis, the facilities were classified into three broad categories
that combined: basic facilities made up of health posts (HPs),
clinics and maternal health centres (MCH); health centres; and
hospitals.
Data for modelling health care utilisation for treatment of fever
was obtained from the national MIS carried out between
September and October 2011 (n=15,442 individuals)[25]. The
MIS was conducted in 21 provinces, across the diverse malaria
strata (medium to high risks; low risk; and very low or potentially
malaria free areas) in Afghanistan, but excluded the southern
regions for security reasons. A multi-stage probability sampling
design was adopted in line with other MIS surveys conducted in
sub-Saharan countries [26]. At the first stage clusters or villages
were selected randomly in a district via probability sampling while
at the second stage, households within the selected clusters were
sampled randomly [25]. Self-reported treatment seeking behav-
iour, disaggregated by healthcare sector, was recorded for all
household members that reported an episode of fever two weeks
prior to the survey. A gridded population surface for Afghanistan
was obtained from Asiapop at 100 m x 100 m spatial resolution
(http://www.worldpop.org.uk/)[27].
Analysis
Analysis of public sector utilisation and defining the
denominator for modelling incidence
A combination of land cover, elevation, road and river data
layers was used to generate a gridded cost surface of travel time
between patient origins (households) and destinations (public
health facilities) as described elsewhere [28] and in File S1. Travel
times were extracted for each MIS cluster and used to predict the
probability of health facility attendance based on reported fever
treatment. A probability of attendance was modelled spatially at
1 km by 1 km resolution and combined with population density to
generate a population-weighted surface for fever treatment. The
population-weighted counts, used in modelling incidence, were
extracted based on a 2-hour cut off based on the modelled distance
decay curves (SI). The catchment population was adjusted for
reporting rates at the facilities calculated as a ratio of received
reports to the expected number over the four-year period.
Modelling incidence of P. falciparum and P. vivax in
Afghanistan
To model the incidence of malaria, HMIS data were compiled
from cases aggregated at each facility for each month. A number
of environmental covariates such temperature suitability index
(TSI), precipitation and enhanced vegetation index (EVI) that are
known to affect malaria transmission were assembled (SI). The
selection of covariates was based on previous studies [19] as well as
aiming for a minimum set to achieve parsimony based on bestglm
package in R [29]. These covariates were extracted and matched
to each data point in space and time. Environmental covariates
were used in a Bayesian zero-inflated conditional autoregressive
(CAR) model to predict incidence at the district level. Since 60%
of data were zeros, a zero – inflated Poisson distribution was used,
generalized as [30,31];
f (y,Q,m)*
Qiz(1{Qi) e
{l
(1{Qi) Po(y, m)
(
yi~0
yiw0
ð1Þ
for the ith space-time observation and 0vQiv1. The probability is
defined via a two-component mixed model such that the
probability is Qi with ‘structural’ zero or defaulting to a general
Poisson model (Pr (X~k)~lke{l=k!). In general mi can depend
on a set of covariates such that:
f y,p,mð Þ~ 1{pij
 
Po y,0ð ÞzpijPo y, exp azbTXij
   ð2Þ
with a (equation 2) forming the intercept modified by a q | 1
vector of Xijcovariates with unknown coefficients b. Further,
log (mi)~
Pk
j~1
xijbj while log it(pij)~ log½pij=(1{pij). Thus, the
zero-inflated probability increases the chance of predicting
‘structural’ zero [32,33]. Random effects were introduced at three
levels of the health facility, district and province in the Bayesian
framework. A spatial effect prior Qs(i)*N(0,t
2
strQ
{1) was intro-
duced at the district level to account for spatial heterogeneity.
Model specification was completed by assigning priors to the
remaining hyper-parameters (the unstructured random effects).
Inverse Gamma priors IG(a,b) were assigned to precision
hyperparameters for these unstructured effects components
hunstr*N(0,t2). The time interaction was modelled as a first-
order auto-regressive process, rY (si,ti{1) with the first term
coming from a stationary distribution N(0,s2w
P
) that depends on
past values for 0wrv1 [34]. Full details of implementation can be
found in File S1.
Posterior predictions were made at the district level along with
associated standard errors. Four spatio-temporal models were
compared to assess the effect of the introduced random effects at
province and facility level as well as the inclusion of the covariates.
The first two models (referred to as M1 and M2) did not include
any covariates with random effects excluded for the first model
(M1). The other two models (M3 and M4) included environmental
covariates, with M3 excluding random effects at facility and
province level. Comparisons were made using the deviance
information criterion (DIC) [35]. This approach simplifies model
selection to a single value, which can be easily tabulated for
comparison with proper Bayesian interpretation. A subset
comprising 10% of the data selected randomly was used
independently to compare posterior prediction against the crude
incidence. Additionally, model checking was implemented by
assessing the variance and the standard error of the predictive
distribution [36].
Results
Data characteristics and public sector utilisation in
Afghanistan
In modelling healthcare utilisation, a list of the universe of
public health facilities was used (n=1,581) from the 34 provinces.
There were more health posts (n=754) compared to health
centres (n=698) and hospital (n=129). The majority were run by
NGOs that work in partnership with the Ministry of Public Health
(MOPH). The malaria case reporting rate was low for basic health
facilities (an average of 33% for the four years) compared to
hospitals and health centres where the reporting rate was .70%.
Of the estimated population (32.3 million) in 2011, 27.8 million
(85.8%) were estimated to be within 2 hours’ of travel of a public
Malaria Incidence in Afghanistan 2006-2009
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health facility; 17.9 million (64.4%) were within 30 minutes.
Approximately 13.1 million (47.4%) were within distances where
the probability of attendance was $60% (SI).
Posterior predictions of incidence of P. falciparum and P.
vivax
Table 1 lists the four Bayesian spatio-temporal models
implemented along with associated model parameters for both
P. vivax and P. falciparum. According to the DIC, the fourth
model (M4) provided the best trade-off between model fit and
parsimony compared to the other three models, although with
more effective parameters PD. For both P. vivax and P.
falciparum, the standard error in M4 of the predictive distribution
was also lower. This model was subsequently selected for analysis
of incidence of P. vivax and P. falciparum. Overall mean error of
the crude incidence and the predicted incidence per 1000
population per year, based on a 10% validation set was 20.30
and 20.44 for P. vivax and P. falciparum respectively showing an
overall tendency to under-predict by less than 0.5 incident cases
per 1000 population. The Pearson correlation based on the
validation set was 0.63 for P. vivax and 0.62 for P. falciparum.
Table 2 lists the posterior summaries of the parameters
representing the fixed effects, the unstructured components, and
the temporal and spatial parameters for both the P. vivax and P.
falciparum models. None of the covariate parameters were
significant at 95% Bayesian credible interval (Crl) based on the
P. falciparum model but temperature suitability (0.123, 95% Crl
0.046–0.202) was significant based on the P. vivax model. All
other model parameters were significant at 95% Crl.
Figure 1 shows the monthly variation of incidence for P. vivax
and P. falciparum for the four-year period. The incidence of P.
vivax peaked in August (7.611 95% Crl 4.849–11.721) compared
to P. falciparum which peaked in November (mean incidence per
1,000 population was 2.403 95% Crl 0.929–5.276). P. falciparum
was lowest in May (0.830 95% Crl 0.303–1.783). Figure 2 and
Figure 3 shows maps of monthly incidence of P. vivax and P.
falciparum, respectively, at district level. The incidence of P.
falciparum was generally very low compared to P. vivax.
Nangahar, Kabul and Kunar had highest estimated clinical
burden of P. vivax and P. falciparum while lowest estimated
burden was in districts bordering Iran in Nimroz and Farah and in
northern Afghanistan. The predicted mean incidence in the most
recent data year (2009) for P. vivax was 5.4 (95% Crl 3.2–9.2)
cases per 1,000 population and 1.2 (95% Crl 0.4–2.9) cases per
1,000 population for P. falciparum. Comparison between the
baseline in 2006 and in 2009 showed small change in incidence
(4.9, 95% Crl 3.0–7.8 and 5.1, 95% Crl 3.2–8.1 respectively for P.
vivax; 1.1, 95% Crl 0.3–2.4 and 1.1, 95% Crl 0.3–2.5 respectively
for P. falciparum) (Figure 4). However, there was a slight increase
in malaria incidence in 2008 for both P. vivax and P. falciparum
as predicted by the model, but, subsequently dropped to the 2006
level in 2009. The mean percentage change in incidence in the 34
provinces between the baseline year and 2009 for P. vivax was 3.0
and 5.9 for P. falciparum (Table 3). P. vivax reduced in 17 of the
34 provinces in Afghanistan while P. falciparum reduced in 13
provinces.
Table 3 provides summaries of population at risk by region. Of
the 30.6 million people in 2009, the estimated burden of P. vivax
in 2009 was 165,712 compared to 36,077 for P. falciparum.
Approximately 32% of the population lived in regions where P.
vivax was greater than 1 case per 1000 population compared to
23.7% for P. falciparum. About 1.3% of the population were
estimated to live in districts with,1 case per 1,000 population and
the majority (66.7%) in districts of 1 to,5 P. vivax cases per 1,000
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Table 2. Parameters of the selected Bayesian models (M4) for both P. falciparum and P. vivax (sequentially as intercept b0, EVI, TSI,
Precipitation, random effects at (facility, district and province), temporal parameter and spatial CAR prior effect Q, SD is the
Standard Deviation).
Parameter Mean SD 5% 50% 95%
P. falciparum Intercept (b0) 23.630 0.387 24.244 23.633 23.008
EVI (b1) 20.031 0.079 20.162 20.031 0.099
TSI (b2) 0.164 0.127 20.042 0.163 0.334
Precipitation (b3) 0.008 0.051 20.077 0.008 0.091
Facility random effect (t1) 1.940 1.903 0.192 1.380 5.534
District random effect (t2) 2.484 0.829 1.355 2.369 4.010
Province random effect (t3) 3.668 1.164 2.040 3.521 5.838
Rho for the month (r) 0.849 0.117 0.617 0.881 0.969
Spatial effect (Q) 5.492 4.535 0.698 2.376 20.970
P. vivax Intercept (b0) 22.065 0.240 22.451 22.069 21.662
EVI (b1) 20.026 0.019 20.058 20.026 0.005
TSI (b2) 0.124 0.048 0.046 0.124 0.202
Precipitation (b3) 0.013 0.011 20.005 0.013 0.031
Facility random effect (t1) 8.383 1.778 6.095 8.057 11.750
District random effect (t2) 2.081 1.976 0.181 1.500 5.888
Province random effect (t3) 7.972 3.953 3.897 6.922 15.530
Rho for the month (r) 0.728 0.098 0.551 0.737 0.872
Spatial effect (Q) 3.141 0.983 1.759 3.024 4.933
The betas represent the fixed effects of the covariates.
doi:10.1371/journal.pone.0102304.t002
Figure 1. Time series of two malaria parasites. Plots showing the predicted monthly (n= 48 months) incidence for (2006–2009) for P. vivax
(mean as top dash-dot line) and for P. falciparum (mean as green dash line) with error bars for each moth showing 95% Bayesian credible interval
(Crl). P. vivax formed the most burden in Afghanistan and its incidence peaked in July and August compared to P. falciparum that peaked later in the
year in November.
doi:10.1371/journal.pone.0102304.g001
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population. Of the remaining population, only 23.3% were in
districts with 5 to,10 cases per 1,000 population, 8.4% in 10 to,
20 cases per 1,000 population and 0.3% of the population. The
latter comprised of populations in eastern Afghanistan in Kunar
and Nangarhar provinces. For P. falciparum case incidence,
76.3% of the population lived in districts where annual incidence
was ,1 per 1,000 population, while 20.9% lived in areas were
incidence of P. falciparum was 1 to,5 cases per 1,000 population.
A minority (2.8%) of the population lived in districts with an
estimated annual incidence of 5 to,10 P. falciparum cases per
1,000 population.
Discussion
In this study we have developed a modelling approach that
combines household and routine HMIS data within a Bayesian
hierarchical spatial-temporal model, to compute the annual
incidence of P. vivax and P. falciparum malaria across 398
districts in Afghanistan. The findings demonstrate a strong
geographic co-distribution of P. vivax and P. falciparum malaria
morbidity in Afghanistan (Figure 2 and Figure 3). There was no
significant change in the mean annual incidence between 2006
and 2009. The incidence of P. vivax and P. falciparum in 2009
were estimated to be 5.4 and 1.2 per 1000 population respectively.
The incidence (for both parasites) was higher in the south-eastern
and eastern parts of Afghanistan bordering Pakistan and lowest in
northern districts. In addition, the analysis showed that malaria in
Afghanistan exhibits a strong seasonal peak between July and
November. P. vivax tended to peak in August (mean incidence of
7.611 95% Crl 4.849–11.721) compared to P. falciparum which
peaked in November (mean incidence 2.403 95% Crl 0.929–
5.276). However, incidence was low in the winter months between
January and May for both parasites. Slightly more than 76% of
districts in Afghanistan had predicted incidence of,1 per 1000
population for P. falciparum which is a threshold for pre-
elimination.
Using the 2006 data as baseline estimates, 17 and 13 provinces
had already reduced P. vivax and P. falciparum incidence
respectively by 2009. No reduction in incidence was predicted for
Nangahar, Balkh, Sari Pul, Khost and Hirat Nangahar and Khost
provinces in south-eastern regions of Afghanistan were amongst
those with highest predicted incidence for both parasites. A range
of malaria control strategies are implemented at a national level in
Afghanistan. LLIN, for example, is targeted in the high to medium
risk districts in Badakhshan, Badghes, Baghlan, Balkh, Faryab,
Herat, Helmand, Kandahar, Khost, Kunar, Kunduz, Laghman,
Nangarhar and Takhar. From the MIS undertaken in 2008,
Nangahar had an estimated long lasting insecticidal nets (LLINs)
coverage of 19% while no LLINs use was observed in Hirat [37].
Sari Pul region, for example, had some of lowest rates of long
lasting insecticidal nets (LLINs) coverage and access to treatment
of care. In the districts where indoor residual spraying (IRS) is used
as the main vector control approach or to complement LLINs, the
targeting of this intervention should be informed by the lag in the
Figure 2. Monthly maps of P. vivax. Maps showing the predicted posterior mean monthly incidence of P. vivax per 1000 population for
Afghanistan in 2009 using a Bayesian CAR model with environmental covariates (rainfall, TSI and EVI). Cases comprised of parasitologically confirmed
and clinical cases corrected for slide positivity rates at the facility for a four-year period (2006–2009). Random unstructured effects were included at
the facility level to account for regional heterogeneity. The highest burden of P. vivax (exceeding 15 cases per 1000 population) was in southeastern
and the eastern regions bordering Pakistan.
doi:10.1371/journal.pone.0102304.g002
Malaria Incidence in Afghanistan 2006-2009
PLOS ONE | www.plosone.org 6 July 2014 | Volume 9 | Issue 7 | e102304
peak season of the two main malaria parasites. P. vivax peaks in
August while P. falciparum peaks in November. IRS campaigns
should therefore be planned in such away the insecticide are
efficacious through the two peak seasons.
Of the 34 provinces of Afghanistan, five (Bamyan, Ghazni,
Ghor, Panjsheer and Nuristan) were considered to be malaria free
based on altitude thresholds [38]. These provinces, however,
accounted for 9.7% of all estimated cases in 2009 indicating a
Figure 3. Monthly maps of P. falciparum. Maps showing the predicted monthly incidence of P. falciparum per 1000 population for Afghanistan in
2009 using a Bayesian CAR model with environmental covariates (rainfall, TSI and EVI). Malaria cases comprised of parasitologically confirmed and
clinical cases corrected for slide positivity rates at the facility. Random unstructured effects were included at the facility level to account for regional
heterogeneity. P. falciparum constitutes less than 10% of the malaria burden in Afghanistan and experienced a late peak in the year (November).
doi:10.1371/journal.pone.0102304.g003
Figure 4. Incidence change plot at district level. Plot showing the differences in malaria incidence per 1000 population (y-axis) between the
baseline year (2006) plotted as blue triangles and incidence for 2009 (hollow red circles). The x-axis represents districts (n=398). The positive change
denoting increase in plotted vertically upwards from the baseline year while negative denoting a reduction in incidence is vertically downwards from
the baseline with the length indicating magnitude of change. Overall percentage change for P. vivax was 3.0 and 5.9 for P. falciparum.
doi:10.1371/journal.pone.0102304.g004
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potential problem of importation of malaria cases due to human
population movement in Afghanistan or foci transmission in
valleys where climatic conditions are favourable. The available
data, however, do not provide malaria case definitions and it is
impossible to distinguish between imported and local cases. In the
malaria free provinces, suspected imported infections should be
documented and algorithms, based mainly on travel history, could
be used as the basis for case definitions [39]. In addition, health
advice and chemoprophylaxis for travellers from the malaria free
to endemic provinces should be initiated as an additional package
for malaria prevention. An incidence of less than 1 P. falciparum
case per 1000 individuals is considered to be the threshold for pre-
elimination by the WHO [40]. By 2009, 21 provinces in
Afghanistan had already achieved such a threshold. However,
the biggest challenge is likely to be operational and a compre-
hensive analysis of overall feasibility of P. falciparum elimination
[41].
The results of our analysis also have important applications to
the design and allocation of resources for malaria case manage-
ment. Mixed infections especially with P. vivax and P. falciparum
present a challenge for treatment [42]. P. vivax infections relapse
from dormant liver-stage hypnozoites months after primary
infections and are often difficult to diagnose and treat and define
as true incident infections [43]. Chloroquine is used as first line
treatment of P. vivax in Afghanistan as recommended for
countries where it remains efficacious and where parasites can
be isolated [44], while Artesunate + Sulfadoxine-Pyrimethamine
(AS+SP) is used for P. falciparum [15]. The incidence maps
developed in our study can be used to quantify the need for the
number of treatment dosages required for both parasites in
Afghanistan. The prevalence of Glucose-6-Phosphate Dehydroge-
nase (G6PD) deficiency is estimated to be 8% in Afghanistan [45]
which complicates the use of the reccomended 14 day regiment of
primaquine (PQ) for P.vivax [46]. The use of PQ in patients with
G6PD deficiency can cause severe haemolysis [47]. To improve
the existing information on the prevalence of G6PD deficiency
these maps can be used to provide P. vivax incidence information
that would be useful for the design of G6PD surveys. Where both
species are endemic, the use of ACTs has been proposed [48,49]
and other clinical studies have shown a faster parasite clearance
rate when ACTs were used [50]. Figure 2 and Figure 3 indicates
Kunar, Khost, Laghman, Nangarhar, Takhar and some districts
in Kandahar could benefit from such a case management
approach.
Although HMIS data used in this analysis represent individuals
presenting with fever (symptomatic cases) and with a greater
chance of detecting an infection, diagnosis was mainly based on
either microscopy or Rapid Diagnostic Test (RDT), both of which
have varying sensitivities [51]. In low transmission setting, the rate
of false positivity rates, when using RDTs, may be higher and the
quality of microscopy in routine HMIS data with varying
laboratory conditions may also vary [52]. In addition, it was not
possible to identify which diagnosis was used at each facility to
adjust the sensitivities. A combination of factors might have limited
the effect of environmental covariates especially for P. falciparum.
This relates to assumptions of linearity during modelling even
though rainfall was lagged by four months (SI) and given the short
time-series of the data (four years). We used an autoregressive
time-varying factor in the model assuming that present state
evolves from previous values, but modified by the set of spatial and
spatio-temporal covariates[34]. Future studies should relax the
linearity assumptions of the fixed effects. Another limitation of the
data presented here is that the effects of migration or travel
between various regions were not incorporated into the modelling
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framework. A study in south-eastern Afghanistan showed higher
asymptomatic infections in the migrant population [53]. Model-
ling migration patterns at national level was beyond the scope of
this study. It was assumed that individuals would seek treatment at
the nearest facility or at least within a district or one of its
neighbours. In this study we have modelled malaria morbidity at
the facility level and explicitly modelled healthcare attendance at
individual facilities as part of our methodology. Security or conflict
remains an important factor affecting utilisation of healthcare
facilities. This was not modelled in the study due to lack of data,
but future studies should consider accounting for this effect on
reported health events. Given the additional spatial precision
resulting from the facility-level analysis representing febrile
individuals within facility catchments, maps of both malaria
species are useful for concerted planning.
Conclusion
This study demonstrates how HMIS and household survey data
can be assembled, integrated and interpolated to identify districts
with high malaria burden spatially and temporally. Maps were
produced at the level of decision-making units, which are
potentially useful to the malaria control programme in assessing
the changing burden of disease in Afghanistan, targeting malaria
interventions at the population most at risk, and planning health
resources. The districts identified with high burden should be the
focus for targeting vector control. Districts with both P. vivax and
P. falciparum and high rates of mixed infections should be
investigated and careful case management strategies adopted.
Improved case definition to determine levels of imported risks in
malaria free areas is necessary for the elimination ambitions in
Afghanistan.
Supporting Information
File S1 The analysis of public healthcare utilisation for treatment
of fever and Bayesian model specification for modelling incidence
is provided in the supplementary information. For healthcare
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of attendance for fever treatment and delineation of public health
facility catchments to estimate population using public health
facilities. For incidence modelling, the supplementary information
includes details on model specification, parameter estimation and
validation.
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